Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperthermia × Ifosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 76 Lymphoma 54 Lymphoma, Large B-Cell, Diffuse 49 Osteosarcoma 29 Lymphoma, Non-Hodgkin 28 Hodgkin Disease 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Burkitt Lymphoma 21 Testicular Neoplasms 19 Leukemia 18 Ovarian Neoplasms 17 Neuroectodermal Tumors, Primitive, Peripheral 17 Lymphoma, Follicular 16 Lymphoma, Large-Cell, Immunoblastic 13 Fibrosarcoma 13 Testicular Germ Cell Tumor 12 Teratoma 12 Rhabdomyosarcoma 12 Recurrence 12 Lymphoma, Mantle-Cell 12 Neurofibrosarcoma 11 Lymphoma, Large-Cell, Anaplastic 11 Liposarcoma 11 Leiomyosarcoma 11 Histiocytoma, Malignant Fibrous 11 Sarcoma, Synovial 10 Neuroblastoma 10 Lymphoma, B-Cell, Marginal Zone 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Hemangiosarcoma 10

Interventions

Diathermy 16 Radiotherapy 9 Cisplatin 5 Drug Therapy 4 Radiation 3 Melphalan 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Cytoreduction Surgical Procedures 3 Brachytherapy 3 tislelizumab 2 Immunotherapy 2 Doxorubicin 2 Conization 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Surgical Procedures, Operative 1 Solutions 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1 Laparotomy 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡